A groundbreaking new study reveals how a single drug has transformed the treatment of certain cancers, offering unprecedented survival rates for patients who previously faced grim prognoses. Researchers detail how the therapy works by harnessing the body’s immune system to target tumors with remarkable precision, marking a shift from traditional chemotherapy. The findings, published in a leading medical journal, suggest this approach could redefine cancer care—but experts warn challenges remain in making it widely accessible. For those battling advanced disease, the results offer a glimmer of hope amid decades of stagnation in treatment breakthroughs.
